Alaunos Therapeutics (TCRT) News Today → Next President (Not Trump. Not Biden.) (From The Freeport Society) (Ad) Free TCRT Stock Alerts $1.16 -0.06 (-4.92%) (As of 05/17/2024 08:54 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 16, 2024 | investorplace.comTCRT Stock Earnings: Alaunos Therapeutics Reported Results for Q1 2024April 12, 2024 | seekingalpha.comRevolution Medicines: An Expensive Shot At A Massive Market OpportunityApril 8, 2024 | investorplace.comTCRT Stock Earnings: Alaunos Therapeutics Misses EPS for Q4 2023April 1, 2024 | msn.comBiora Therapeutics announces $6M registered direct offering and concurrent private placementFebruary 2, 2024 | marketbeat.comAlaunos Therapeutics (NASDAQ:TCRT) Trading 9% Higher Alaunos Therapeutics (NASDAQ:TCRT) Stock Price Up 9%February 1, 2024 | marketbeat.comTrading was temporarily halted for "TCRT" at 07:01 PM with a stated reason of "News pending."January 31, 2024 | msn.comAlaunos Therapeutics Announces 1-for-15 Reverse Stock SplitJanuary 31, 2024 | investing.comWerewolf Therapeutics Inc (HOWL)December 28, 2023 | benzinga.comAlaunos Therapeutics Stock (NASDAQ:TCRT) Dividends: History, Yield and DatesNovember 14, 2023 | benzinga.comRecap: Alaunos Therapeutics Q3 EarningsNovember 14, 2023 | investorplace.comWhy Is Alaunos Therapeutics (TCRT) Stock Up 14% Today?November 14, 2023 | finance.yahoo.comAlaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic AlternativesNovember 1, 2023 | morningstar.comAlaunos Therapeutics Inc TCRTAugust 15, 2023 | msn.comWhy Is Alaunos Therapeutics Sinking Today?August 14, 2023 | finance.yahoo.comAlaunos Therapeutics Announces Second Quarter 2023 Financial Results, Interim Clinical Data and Exploration of Strategic AlternativesAugust 14, 2023 | marketbeat.comTrading was temporarily halted for "TCRT" at 04:08 PM with a stated reason of "News pending."June 29, 2023 | finance.yahoo.comAlaunos Therapeutics Announces Presentation at the 2nd Hawaii Global Summit on Thoracic MalignanciesJune 9, 2023 | benzinga.comAlaunos Therapeutics Stock (NASDAQ:TCRT), Insider Trading ActivityMay 26, 2023 | msn.comAlaunos slips 17% on Phase 1/2 data for cancer cell therapyMay 25, 2023 | finance.yahoo.comAlaunos Therapeutics to Present Early Data from TCR-T Library Phase 1/2 Trial at 2023 American Society of Clinical Oncology Annual MeetingMay 17, 2023 | uk.news.yahoo.comOne Alaunos Therapeutics Insider Raised Stake By 117% In Previous YearMay 15, 2023 | seekingalpha.comAlaunos Therapeutics upgraded to buy at Wainwright on multiple catalystsMay 13, 2023 | finance.yahoo.comAlaunos Therapeutics, Inc. (NASDAQ:TCRT) Q1 2023 Earnings Call TranscriptMay 11, 2023 | marketwatch.com8-K: Alaunos Therapeutics, Inc.May 10, 2023 | finanznachrichten.deAlaunos Therapeutics, Inc.: Alaunos Therapeutics Reports First Quarter 2023 Financial ResultsMay 10, 2023 | msn.comAlaunos Therapeutics GAAP EPS of -$0.04 in-lineMay 10, 2023 | msn.comRecap: Alaunos Therapeutics Q1 EarningsMay 10, 2023 | finance.yahoo.comAlaunos Therapeutics Reports First Quarter 2023 Financial ResultsMay 3, 2023 | finance.yahoo.comAlaunos Therapeutics to Report First Quarter 2023 Financial Results on May 10, 2023April 26, 2023 | finance.yahoo.comAlaunos Therapeutics Announces Poster Presentation at the American Society of Clinical Oncology (ASCO) 2023 Annual MeetingApril 25, 2023 | finance.yahoo.comThe past five years for Alaunos Therapeutics (NASDAQ:TCRT) investors has not been profitableApril 2, 2023 | barrons.comAlaunos Therapeutics Inc.March 30, 2023 | finance.yahoo.comAlaunos Therapeutics Appoints Dr. Robert J. Hofmeister to Board of DirectorsMarch 29, 2023 | finance.yahoo.comAlaunos Therapeutics to Participate in Upcoming Investor Conferences in AprilMarch 13, 2023 | marketbeat.comAlaunos Therapeutics, Inc. (NASDAQ:TCRT) to Post FY2023 Earnings of ($0.17) Per Share, Cantor Fitzgerald ForecastsAlaunos Therapeutics, Inc. (NASDAQ:TCRT - Get Rating) - Analysts at Cantor Fitzgerald dropped their FY2023 earnings estimates for Alaunos Therapeutics in a report released on Wednesday, March 8th. Cantor Fitzgerald analyst P. Agrawal now anticipates that the company will earn ($0.17) per share foMarch 10, 2023 | finance.yahoo.comWhen Will Alaunos Therapeutics, Inc. (NASDAQ:TCRT) Turn A Profit?March 10, 2023 | marketbeat.comQ1 2023 EPS Estimates for Alaunos Therapeutics, Inc. Increased by HC Wainwright (NASDAQ:TCRT)Alaunos Therapeutics, Inc. (NASDAQ:TCRT - Get Rating) - Equities research analysts at HC Wainwright boosted their Q1 2023 EPS estimates for Alaunos Therapeutics in a research report issued to clients and investors on Wednesday, March 8th. HC Wainwright analyst S. Ramakanth now forecasts that theMarch 9, 2023 | msn.comAlaunos Therapeutics's Return On Capital Employed OverviewMarch 9, 2023 | finance.yahoo.comAlaunos Therapeutics, Inc. (NASDAQ:TCRT) Q4 2022 Earnings Call TranscriptMarch 6, 2023 | msn.comEarnings Outlook For Alaunos TherapeuticsMarch 3, 2023 | msn.comAlaunos (TCRT) to Report Q4 Earnings: What's in the Cards?March 1, 2023 | finance.yahoo.comAlaunos Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on March 7, 2023February 28, 2023 | marketbeat.comErgoteles LLC Has $835,000 Holdings in Alaunos Therapeutics, Inc. (NASDAQ:TCRT)Ergoteles LLC trimmed its position in Alaunos Therapeutics, Inc. (NASDAQ:TCRT - Get Rating) by 48.2% in the third quarter, according to its most recent filing with the SEC. The fund owned 485,434 shares of the company's stock after selling 451,466 shares during the period. Ergoteles LLC owned 0.22%February 17, 2023 | finance.yahoo.comAlaunos Therapeutics, Inc.'s (NASDAQ:TCRT) largest shareholders are individual investors with 58% ownership, institutions own 22%January 24, 2023 | finance.yahoo.comIs Alaunos Therapeutics (TCRT) Outperforming Other Medical Stocks This Year?January 13, 2023 | marketbeat.comFY2022 EPS Estimates for Alaunos Therapeutics, Inc. Lifted by Analyst (NASDAQ:TCRT)Alaunos Therapeutics, Inc. (NASDAQ:TCRT - Get Rating) - Research analysts at Cantor Fitzgerald lifted their FY2022 earnings estimates for shares of Alaunos Therapeutics in a note issued to investors on Tuesday, January 10th. Cantor Fitzgerald analyst P. Agrawal now forecasts that the company willJanuary 9, 2023 | finance.yahoo.comAlaunos Therapeutics Highlights Strategic Priorities and Anticipated Portfolio Milestones for 2023December 29, 2022 | finance.yahoo.comAlaunos Therapeutics, Inc. (NASDAQ:TCRT) Q3 2022 Earnings Call TranscriptDecember 4, 2022 | uk.news.yahoo.comTrade Alert: The Independent Director Of Alaunos Therapeutics, Inc. (NASDAQ:TCRT), Jaime Vieser, Has Just Spent US$813k Buying 117% More SharesDecember 1, 2022 | marketbeat.comAlaunos Therapeutics, Inc. (NASDAQ:TCRT) Director Robert W. Postma Buys 750,000 SharesAlaunos Therapeutics, Inc. (NASDAQ:TCRT - Get Rating) Director Robert W. Postma bought 750,000 shares of Alaunos Therapeutics stock in a transaction dated Tuesday, November 29th. The stock was acquired at an average price of $0.65 per share, with a total value of $487,500.00. Following the purchase, the director now directly owns 5,000,000 shares of the company's stock, valued at $3,250,000. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Get Alaunos Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TCRT and its competitors with MarketBeat's FREE daily newsletter. Email Address Shocking $16T Elon Musk Crypto Leak (Ad)Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run. Click here now to get your copy. TCRT Media Mentions By Week TCRT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TCRT News Sentiment▼0.690.42▲Average Medical News Sentiment TCRT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TCRT Articles This Week▼20▲TCRT Articles Average Week Get Alaunos Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TCRT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Lumos Pharma News Orgenesis News Synlogic News MEI Pharma News BioVie News NeuroBo Pharmaceuticals News KALA BIO News Benitec Biopharma News Cocrystal Pharma News Cumberland Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TCRT) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaElon’s New Device is About to Shock the WorldInvestorPlaceBiden Nomination CANCELED?The Freeport SocietyUrgent Nvidia WarningAltimetryShocking: One AI startup's revenue could surge 4,735%Manward Press"The Biggest Drug Ever" Is ComingBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersMost important medical advance in 100 yearsThe Oxford Club Adding Choose a watchlist: Watchlist My Default Watchlist Adding Alaunos Therapeutics, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.